from Paceomics at http://bit.ly/1U5v7WS on June 30, 2015 at 09:32PM Featuring introduction by Genome Alberta CSO Dr. Gijs van Rooijin, and PACEOMICS Profs Christopher McCabe, University of Alberta and Richard Gold, McGill University, as well as Prof. Wylie Burke, University of Washington. Connect here: http://bit.ly/1Nvz2r0 Advertisements
from Knowledge@Wharton » Health Economics at http://whr.tn/1NtfAM4 on June 30, 2015 at 07:47PM While pharmaceutical companies hope their television ads might convince a consumer to choose their drug over a rival’s, new Wharton research finds that the ads have a number of additional, unintended impacts.
from THCB at http://bit.ly/1NtfC6x on June 30, 2015 at 10:08PM By KIM KRUEGER Every quarter, Health 2.0 releases a summary set of data that explains where industry funding is going, which product segments are growing fastest, and where new company formation is happening. Health 2.0’s precision and clarity when it comes to market segmentation and […]
from ScienceDirect Publication: Journal of Health Economics at http://bit.ly/1HvT9qB on June 30, 2015 at 08:16PM Publication date: Source:Journal of Health Economics Author(s): Yuping Tsai
from ScienceDirect Publication: Journal of Health Economics at http://bit.ly/1HvT8TE on June 30, 2015 at 08:16PM Publication date: Source:Journal of Health Economics Author(s): Paul Brown , Laura Panattoni , Linda Cameron , Stephanie Knox , Toni Ashton , Tim Tenbensel , John Windsor
from The Incidental Economist at http://bit.ly/1IqDCY0 on June 30, 2015 at 07:31PM The Supreme Court ruled against the plaintiffs in King vs. Burwell. In the aftermath, Michael Cannon, a principal architect of the plaintiffs’ suit, wrote that the battle to set in place a health care system that works for all Americans is far from over. […]
from Google Alert – “health economics” at http://bit.ly/1FO3F56 on June 30, 2015 at 04:33PM